Nausea and gastrointestinal symptoms are the most frequently reported side effects, affecting up to 40% of patients initiating therapy
Protecting Muscle: The Key to Safe Menopause Weight Loss Because a GLP-1 lowers appetite, the biggest risk during menopause weight loss is losing muscle along with fat
Because real-world weight loss often differs from weight loss in a clinical trial, the study will provide better insight into what to expect when not in a controlled environment, she says
Yes, semaglutide can cause fatigue, particularly during initial treatment due to gastrointestinal side effects, inadequate caloric intake, dehydration, or hypoglycemia when combined with insulin or sulfonylureas
Initial dose: 0.25 mg once weekly Increase to 0.5 mg at four weeks Potentially increase to 1.0 mg at eight weeks Maintenance dose up to 2.4 mg weekly, based on individual response Every step of the semaglutide weight loss program is watched by healthcare professionals